Actylis is a New York–based manufacturer and supplier of critical raw materials with over 75 years of experience. The company currently operates in 10 countries across North America, Europe, and Asia. Actylis provides comprehensive API development and manufacturing, and their GMP APIs are currently employed in dermal, ophthalmic, nasal, and OTC drug formulations. They provide GMP manufacturing of innovative APIs, excipients, and late-stage intermediates, as well as IND-enabling batch manufacturing and tech transfer.
